Renascience, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Feb 13, 2025 3:30 pm JST Earnings

4889 Renascience Inc. 【J-GAAP】

Earnings Report

Renascience Inc. <4889> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was a reduced loss of 140 million yen (compared to a loss of 221 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the January to March period (4Q) is expected to expand to a loss of 127 million yen (compared to a loss of 30 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the ordinary loss improved to a deficit of 48 million yen (compared to a loss of 127 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	30	-225	-225	-226	-17.8	ー	Feb 9, 2023	J-GAAP
Apr - Dec, 2023	120	-221	-221	-222	-17.5	ー	Feb 8, 2024	J-GAAP
Apr - Dec, 2024	65	-139	-140	154	12.1	ー	Feb 13, 2025	J-GAAP
YoY	-45.8%	+37.1%	+36.7%	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	74	-158	-157	-163	-12.8	0	May 9, 2024	J-GAAP
Oct - Mar, 2024 Guidance	72	-177	-175	118	9.3	0	Dec 6, 2024	J-GAAP
YoY	-2.7%	-12.0%	-11.5%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	100	-333	-333	-335	-26.4	0	May 11, 2023	J-GAAP
Mar, 2024	194	-252	-251	-258	-20.3	0	May 9, 2024	J-GAAP
Mar, 2025 Guidance	127	-267	-267	46	3.6	0	Dec 6, 2024	J-GAAP
YoY	-34.5%	-6.0%	-6.4%	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	0	-127	-127	-127	-10.0	-Inf	Feb 8, 2024	J-GAAP
Jan - Mar, 2024	74	-31	-30	-36	-2.8	-41.9	May 9, 2024	J-GAAP
Apr - Jun, 2024	40	-36	-36	-16	-1.3	-90.0	Aug 8, 2024	J-GAAP
Jul - Sep, 2024	15	-54	-56	-56	-4.5	-360.0	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	10	-49	-48	226	17.8	-490.0	Feb 13, 2025	J-GAAP
YoY	－	+61.4%	+62.2%	－	－